4.6 Article

Hepatitis C virus modified sE2F442NYT as an antigen in candidate vaccine facilitates human immune cell activation

Related references

Note: Only part of the references are listed.
Article Cell Biology

STAT3 signaling in B cells controls germinal center zone organization and recycling

Adam J. Fike et al.

Summary: This study reveals the important role of signal transducer and activator of transcription 3 (STAT3) in germinal centers (GCs). STAT3 deficiency alters GC structure, reducing the development of long-lived plasma cells (LL-PCs) but increasing the number of memory B cells (MBCs). STAT3 regulates GC B cell recycling, maintaining GC zone organization and controlling GC egress of plasma cells while negatively regulating MBC output.

CELL REPORTS (2023)

Article Immunology

Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunity

Tapas Patra et al.

Summary: This study examined the immune protection of different components of HCV vaccines in a BALB/c mouse model. It was found that vaccination with an mRNA-LNP vaccine expressing soluble E1 significantly reduced HCV viral titer in the mouse ovary. However, adding an mRNA-LNP vaccine expressing soluble E2 impaired the efficacy of the E1 vaccine.

NPJ VACCINES (2023)

Article Pharmacology & Pharmacy

The immunomodulatory effect of koumine on B cells under dependent and independent responses by T cells

Yarong Lin et al.

Summary: Koumine has both direct and indirect immunomodulatory effects on B cells, inhibiting their differentiation, activation, and proliferation, and reducing antibody secretion. This may be an important mechanism for its anti-rheumatoid arthritis effect.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Review Biochemistry & Molecular Biology

STAT1 and Its Crucial Role in the Control of Viral Infections

Manlio Tolomeo et al.

Summary: STAT1 protein plays a crucial role in the immune response against viruses, and its deficiency can result in severe infections and even death. It has been found that some viruses inhibit the activity of STAT1, making it important to search for drugs that can target these viral proteins for the treatment of dangerous viral infections and future viral pandemics, as demonstrated by the clinical results with Paxlovid in SARS-CoV-2-infected patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Virology

Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response

Vijayamahantesh Vijayamahantesh et al.

Summary: The study shows that amino acid alteration in the front layer of soluble E2 disrupts its interaction with CD81 and alters the cytokine response. Immunization with modified sE2(F442NYT) protein-mRNA-LNP vaccine generates a stronger proinflammatory response and improved protection against a surrogate HCV vaccinia challenge model in mice. The results suggest that HCV E2 exhibits immunoregulatory activity that inhibits robust protective immune responses. Engineering E2 antigen in an mRNA-LNP platform may provide a novel approach for multigenotype HCV vaccine development.

JOURNAL OF VIROLOGY (2022)

Article Cell Biology

Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening

Jennifer M. Pfaff-Kilgore et al.

Summary: The E1 and E2 envelope proteins of hepatitis C virus (HCV) form a surprisingly fragile complex where even a single alanine mutation at 92% of positions disrupts its function. The identified amino-acid-level targets are highly conserved and functionally critical, providing potential opportunities for improved therapies and vaccines against hepatitis C.

CELL REPORTS (2022)

Review Gastroenterology & Hepatology

T cell immunity to hepatitis C virus: Lessons for a prophylactic vaccine

Robert Thimme

Summary: HCV-specific T cells are essential in determining the outcome of acute infection, yet often fail leading to viral persistence. Limited knowledge about the immunological determinants of viral clearance, persistence and protective immunity is a major obstacle in developing a prophylactic T cell vaccine.

JOURNAL OF HEPATOLOGY (2021)

Article Immunology

Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses

Mohamad-Gabriel Alameh et al.

Summary: Lipid nanoparticle (LNP)-encapsulated nucleoside-modified mRNA vaccines have intrinsic adjuvant activity that enhances durable and protective antibody responses. Compared to the widely used MF59-like adjuvant AddaVax, this LNP formulation outperforms and relies on specific components and cytokine induction for its adjuvant activity.

IMMUNITY (2021)

Review Immunology

Antigen presentation by dendritic cells and their instruction of CD4+T helper cell responses

Kerry L. Hilligan et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Article Gastroenterology & Hepatology

Hepatitis C Virus E2 Envelope Glycoprotein Induces an Immunoregulatory Phenotype in Macrophages

Young-Chan Kwon et al.

HEPATOLOGY (2019)

Review Immunology

The continuing story of T-cell independent antibodies

David Allman et al.

IMMUNOLOGICAL REVIEWS (2019)

Article Immunology

RNA-binding protein Ptbp1 is essential for BCR-mediated antibody production

Hiroki Sasanuma et al.

INTERNATIONAL IMMUNOLOGY (2019)

Review Cell Biology

Regulatory mechanisms of B cell responses and the implication in B cell-related diseases

Dong-Yan Tsai et al.

JOURNAL OF BIOMEDICAL SCIENCE (2019)

Article Medicine, Research & Experimental

IL-23R-activated STAT3/STAT4 is essential for Th1/Th17-mediated CNS autoimmunity

Priscilla W. Lee et al.

JCI INSIGHT (2017)

Article Immunology

The Role of Forkhead Box 1 (FOXO1) in the Immune System: Dendritic Cells, T Cells, B Cells, and Hematopoietic Stem Cells

Adriana Alicia Cabrera-Ortega et al.

CRITICAL REVIEWS IN IMMUNOLOGY (2017)

Article Immunology

Syk Tyrosine Kinase Is Critical for B Cell Antibody Responses and Memory B Cell Survival

Jochen A. Ackermann et al.

JOURNAL OF IMMUNOLOGY (2015)

Article Immunology

Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction

Peter D. Kurktschiev et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2014)

Review Virology

CD81 and Hepatitis C Virus (HCV) Infection

Lucie Feneant et al.

VIRUSES-BASEL (2014)

Article Multidisciplinary Sciences

STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor

Yuxin Wang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Multidisciplinary Sciences

Hepatitis C Virus E2 Envelope Glycoprotein Core Structure

Leopold Kong et al.

SCIENCE (2013)

Review Biochemistry & Molecular Biology

Akt, FoxO and regulation of apoptosis

Xinbo Zhang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)

Article Immunology

The Transcription Factor STAT3 Is Required for T Helper 2 Cell Development

Gretta L. Stritesky et al.

IMMUNITY (2011)

Article Immunology

Batf coordinates multiple aspects of B and T cell function required for normal antibody responses

Briana C. Betz et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2010)

Article Multidisciplinary Sciences

A p38 MAPK-MEF2C pathway regulates B-cell proliferation

Dustin Khiem et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Hematology

STAT3 positively regulates an early step in B-cell development

Wei-Chun Chou et al.

BLOOD (2006)

Review Cell Biology

Controlling the Toll road to dendritic cell polarization

A Mazzoni et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2004)

Article Immunology

B cells regulate autoimmunity by provision of IL-10

S Fillatreau et al.

NATURE IMMUNOLOGY (2002)